Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme

We identified hyaluronan synthase-2 (Has2) as a likely source of hyaluronan (HA) during embryonic development, and we used gene targeting to study its function in vivo. Has2(-/-) embryos lack HA, exhibit severe cardiac and vascular abnormalities, and die during midgestation (E9.5-10). Heart explants...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of clinical investigation Vol. 106; no. 3; pp. 349 - 360
Main Authors Camenisch, T D, Spicer, A P, Brehm-Gibson, T, Biesterfeldt, J, Augustine, M L, Calabro, Jr, A, Kubalak, S, Klewer, S E, McDonald, J A
Format Journal Article
LanguageEnglish
Published United States American Society for Clinical Investigation 01.08.2000
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:We identified hyaluronan synthase-2 (Has2) as a likely source of hyaluronan (HA) during embryonic development, and we used gene targeting to study its function in vivo. Has2(-/-) embryos lack HA, exhibit severe cardiac and vascular abnormalities, and die during midgestation (E9.5-10). Heart explants from Has2(-/-) embryos lack the characteristic transformation of cardiac endothelial cells into mesenchyme, an essential developmental event that depends on receptor-mediated intracellular signaling. This defect is reproduced by expression of a dominant-negative Ras in wild-type heart explants, and is reversed in Has2(-/-) explants by gene rescue, by administering exogenous HA, or by expressing activated Ras. Conversely, transformation in Has2(-/-) explants mediated by exogenous HA is inhibited by dominant-negative Ras. Collectively, our results demonstrate the importance of HA in mammalian embryogenesis and the pivotal role of Has2 during mammalian development. They also reveal a previously unrecognized pathway for cell migration and invasion that is HA-dependent and involves Ras activation.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Address correspondence to: John A. McDonald, Samuel C. Johnson Medical Research Center, Mayo Clinic Scottsdale, 13400 East Shea Boulevard, Scottsdale, Arizona 85259, USA. Phone: (480) 301-8859; Fax: (480) 301-7017; E-mail: mcdonald.john@mayo.edu.
ISSN:0021-9738
DOI:10.1172/jci10272